SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mylan challenges nod to Ranbaxy's $600-mn drug

22 Mar 2011 Evaluate

Ranbaxy’s right to sell a generic version of Pfizer’s cholesterol-lowering drug, Lipitor, in the United States for six months has been challenged in a court. This is considered a $600-million (Rs 2,700 crore) opportunity for the company. US-based Mylan Laboratories has sued the US Food and Drug Administration (FDA) for giving this opportunity to Ranbaxy. The company wants that all generic players including Mylan be allowed to enter the market as soon as the patent protection on Lipitor ends in November.

Ranbaxy holds the right as it was the first to challenge a later date patent on the drug and apply for supply of a generic, low-cost version as soon as the basic patent expires. According to Mylan, Ranbaxy was not eligible for marketing exclusivity because of “false and unreliable data” from its manufacturing site in Paonta Sahib, India, where Lipitor’s copies would be produced. The facility was earlier under the FDA scanner for falsifying data.

Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×